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Pediatric bipolar disorder (PBD) is a seriousmental disorder that affects the development and emotional growth of affected patients.
The brain derived neurotrophic factor (BDNF) is recognized as one of the possible markers of the framework and its evolution.
Abnormalities in BDNF signaling in the hippocampus could explain the cognitive decline seen in patients with TB. Our aim with
this study was to evaluate possible changes in hippocampal volume in children and adolescents with BD and associate them to
serumBDNF. Subjects included 30 patients aged seven to seventeen years from the ProCAB (Program for Children andAdolescents
with Bipolar Disorder). We observed mean right and left hippocampal volumes of 41910.55 and 41747.96mm3, respectively. No
statistically significant correlations between peripheral BDNF levels and hippocampal volumes were found.We believe that the lack
of correlation observed in this study is due to the short time of evolution of BD in children and adolescents. Besides studies with
larger sample sizes to confirm the present findings and longitudinal assessments, addressing brain development versus a control
group and including drug-naive patients in differentmood statesmay help clarify the role of BDNF in the brain changes consequent
upon BD.
1. Introduction
Bipolar disorder (BD) is a severe mental disorder character-
ized bymood swings during which a person has distinct peri-
ods of impairing elevated (mania) or decreased (depression)
mood and energy [1]. It occurs in approximately 0.4 to 1.6%
of adults and in 1% in children and adolescents [2, 3]. In
the early-age onset presentation (pediatric bipolar disorder,
PBD), difficulties in interpersonal relationships, academic
functioning, and negative outcomes such as multiple hospi-
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Despite the devastating effects of BD on child develop-
ment, little is known about the causes of this disorder. Its
etiology is probably multifactorial, including biological and
environmental factors [6]. Studies in adults with BD suggest
that neurotrophins, particularly brain-derived neurotrophic
factor (BDNF), inflammatory markers, and oxidative stress
may be related to the etiology of this disorder [7, 8]. BDNF
is the most abundant neurotrophin in the brain, and it has
been implicated in neuronal processes such as neurogenesis,
neuronal survival, dendritic growth, and synaptic plasticity
[9]. It has been suggested that neuronal viability might be
affected by neurotrophins persistent reduction [10]. Kauer-
Sant’Anna and colleagues found BDNF levels were lower
in patients who had multiple episodes of the disorder,
which led to the hypothesis that episode-related reduction of
neurotrophins could explain some of the structural changes
in the brain observed in bipolar patients [11]. Besides that,
BDNF is highly expressed in the cortex and hippocampus,
areas of the brain known to regulate complex functions such
as memory and emotion.
Structural and functional neuroimaging studies of pedi-
atric BD generally converge with adult studies in implicating
frontolimbic structures [12] and smaller sizes of amygdala
[13] and hippocampus [14, 15], and a significant negative
correlation between the volume of the right hippocampus of
adolescents with BD and disease duration has been reported.
Although these findings are preliminary due to relatively
small sample sizes, hippocampal commitment is consistent
across several investigations.
Altogether, these findings suggest that abnormalities of
BDNF signaling in the hippocampus could be an explanation
to the cognitive deficits observed in PBDand brain alterations
present in adults after multiple episodes [10, 16]. The most
consistent associations between PBD and cognitive deficits
were reported for impairments in working memory, verbal
memory, attention, executive function, response flexibility,
reversal learning, processing speed, set shifting, and visu-
ospatial memory [17].
Due to the involvement of BDNF inBDand its abundance
and influence on neurogenesis in the hippocampus, we
evaluated the correlation between peripheral levels of BDNF
and hippocampal volumetric measurements in children and
adolescents with BD. Furthermore, based on previous studies
showing [1] early cognitive deficits in PBD, we evaluated the
workingmemory of patients with PBD.We also hypothesized
that patients with longer disease duration would present
lower serum BDNF levels, poorer neurocognitive perfor-
mance, and reduced hippocampal volumes.
2. Methods
This was a cross-sectional study. Children and adolescents
with bipolar disorder I, bipolar disorder II, or bipolar disorder
NOS evaluated in the ProCAB (Pediatric Bipolar Disorder
Outpatient Program) of the Hospital de Cĺınicas de Porto
Alegre were invited to participate. Enrollment was performed
from 2012 to 2013. Inclusion criteria were as follows: ages
7–17 years; both genders; bipolar diagnosis I, bipolar diag-
nosis II, or bipolar diagnosis NOS according to DSM-IV.
Of note, since the most representative sample of pediatric
bipolar disorder is the COBY study (Course and Outcome
of Bipolar Youth), our definition BD-NOS followed the same
criteria, that is, at least 4 episodes of 4-hour lasting mood
changes clearly differing from the usual for the subject [18].
Exclusion criteria were as follows: presence of schizophrenia,
pervasive developmental disorder, active substance abuse,
and contraindications to MRI.
2.1. Diagnostic Assessment. All patients underwent a three-
step procedure for diagnosis ascertainment.
First, a child and adolescent psychiatrist performed BD
symptom (DSM-IV and DSM5 criteria) and family history
of mental disorders screening with parents and children
together. A total of 127 subjects were assessed, and 95
(75%) were excluded due to not presenting BD-I, BD-II, or
BD-NOS. Two patients started the assessment but did not
complete it.
When the diagnosis of BD was suspected, patients and
parents went through a semistructured interview with the
schedule for affective disorders and schizophrenia for school-
age children, present and lifetime version (K-SADS-PL),
conducted by a research assistant.
Finally, a clinical evaluation was conducted by a second
child and adolescent psychiatrist that received all information
from previous queries. An important observation is that a
clinical meeting with all the professionals involved in the
assessment was conducted to define diagnosis, comorbidity,
and the treatment plan.
Patients diagnosed with BD-I, BD-II, or BD-NOS under-
went neuropsychological assessment, blood sampling for
BDNF level determination, and MRI. Young Mania Rat-
ing Scale (YMRS) and Children’s Depression Rating Scale
(CDRS) were also applied for the purpose of measuring
manic and depressive symptoms at the evaluation time.
2.2. Neuropsychological or Neurocognitive Assessment.
Full scale IQ was determined using the vocabulary and
block design subsets of the Wechsler Intelligence Scale for
Children-Third Version (WISC-III) and the Digit Span of
the WISC-III (total score and inverse order). According to
previous studies, Digit Span Inverse Order is more directly
correlated with working memory [19].
2.3. Neuroimaging Assessment
2.3.1. Images Acquisition. All patients underwent a 1.5 T
Philips Achieva magnetic resonance imaging (MRI) using
an eight-channel head coil. The structural images were
acquired using a sagittal 3D T1 weighted magnetization-
prepared rapid gradient-echo (MPRAGE) sequence (repe-
tition time = 8.7ms, echo time = 4.0ms, inversion time
= 1000ms, and flip angle = 8∘). Possible head movements
were minimized by placing foam pads inside the head
coil. The volumetric segmentation and measurement were
performed with the FreeSurfer image analysis suite, which
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is documented and freely available for download online
(http://surfer.nmr.mgh.harvard.edu/).
2.3.2. Processing of Structural Images. The image processing
was carried out with support from the National Supercom-
puting Center (CESUP), Federal University of Rio Grande
do Sul [20]. FreeSurfer v 5.3 was installed in the cluster with
Novell SUSELinuxEnterprise Server 11-SP1 operating system.
Each data set subject was allocated to one processing core and
included in the submission queue processing script.
Cortical reconstruction and volumetric segmentation
were performed with the FreeSurfer image analysis suite,
which is documented and freely available for download
online (http://surfer.nmr.mgh.harvard.edu/). Briefly, this
processing includes motion correction and averaging of
multiple volumetric T1 weighted images (when more than
one is available), removal of non-brain tissue using a hybrid
watershed/surface deformation procedure, automated
Talairach transformation, segmentation of the subcortical
white matter, and deep gray matter volumetric structures
(including hippocampus, amygdala, caudate, putamen,
and ventricles) [21, 22]. Automatic segmentation method
was used to measure hippocampal volume. Shortly, a
neuroanatomical label is assigned to every voxel in the
brain, comparing to an atlas whose encoding is based on
class and location classification. This procedure is based on
modeling the segmentation as a nonstationary anisotropic
Markov random field (MRF), in which the probability of a
label is modulated by the probability of its neighbors, with
the probabilities computed separately at each position in an
atlas, for each pair of tissue classes and for each of the six
cardinal directions [21].
2.4. BDNF Serum Levels Determination. BDNF serum levels
were measured with sandwich-ELISA, using a commercial
kit according to the manufacturer’s instructions (Millipore,
USA). Briefly, microtiter plates (96-well flat-bottom) were
coated for 24 h at 4∘C with the samples diluted 1 : 100 in
sample diluent and standard curve ranging from 7.8 to 500 pg
of BNDF. Plateswere thenwashed four timeswithwash buffer
followed by the addition of biotinylated mouse anti-human
BNDF monoclonal antibody (diluted 1 : 1000 in sample dilu-
ent), which was incubated for 3 h at room temperature. After
washing, a second incubation with streptavidin-horseradish
peroxidase conjugate solution (diluted 1 : 1000) for 1 h at
room temperature was carried out. After addition of substrate
and stop solution, the amount of BDNF was determined
(absorbance set in 450 nm).The standard curve demonstrates
a direct relationship between optical density (OD) and BDNF
concentration. Total protein was measured by Bradford’s
method (samples diluted 1 : 200) using bovine serum albumin
(BSA) as a standard.
2.5. Data Analysis. Data analysis was performed using the
Spearman correlation due to the fact that the dependent
variables (hippocampal volume and peripheral levels of
BDNF) had asymmetric distribution. Correlations between
hippocampal volume, BDNF levels, working memory, and
Table 1: Demographic data (𝑁 = 27).
Mean SD
Age (years) 13.89 2.98
Age of onset (years) 9.18 3.79




SD: standard deviation; YMRS: YoungMania Rating Scale; CDRS: Children’s
Depression Rating Scale.
IQ: intelligence quotient.
duration of disorder were also performed. All the analyses
were performed considering raw volumes for the hippocam-
pus and also for a corrected value according to total intracra-
nial volume, due to the high variation in our age range.
SPSS 20 forWindows was used for statistical analyses. All
statistical tests were two-tailed with a set at 0.05.
2.6. Ethical Issues. Children, adolescents, and their parents
were properly informed about the goal of the project and
accepted participating in the protocol and use of data anony-
mously for publications. This project was approved by the
Ethics Committee in Research of the Hospital de Cĺınicas de
Porto Alegre. A statement of informed consent was provided
by the parent or guardian and verbal assent by the patient.
3. Results
During the conduction of this study, 127 patients were
assessed, and 75% were excluded due to not presenting BD-
I, BD-II, or BD-NOS. Two patients started the assessment
but did not complete it. From the 30 patients available for
the protocol, twenty-seven patients completed the entire
evaluation. Three patients did not undergo MRI: one patient
got pregnant, and two patients were not able due to the use
of dental braces. Demographic/clinical data of the subjects
are described in Table 1. The final sample was composed
of 14 male and 13 female subjects, and their mean age
was 13.8 years. The age of onset of bipolar disorder among
patients ranged from 3 to 15 years. Intelligence quotient
(IQ) in the subjects ranged around 105.77 ± 14.05. The
majority of subjects presented bipolar disorder type I (77.7%),
3.7% bipolar disorder type II, and 18.6% BD-NOS. Disease
duration varied from zero to 14 years (average: 4.74; SD: 3.38).
From the 27 patients, 33.3% had comorbid ADHD, 18.5% had
comorbid anxiety disorders, and 18.5% had formal diagnosis
of ODD, as described in Table 2.
Most subjects (77.7%)were taking a number of psychiatric
medications: lithium or valproate monotherapy (𝑛 = 4;
14.8%); atypical antipsychotics monotherapy (𝑛 = 4, 14.8%);
combined lithium plus anticonvulsants/antipsychotics (𝑛 =
6, 22.2%); combined anticonvulsants/antidepressants (𝑛 =
1, 3.7%); multiple combination therapy (𝑛 = 5, 18.5%);
concomitant use of stimulants (𝑛 = 7, 25.9%). The mean
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Anxiety disorders 5 (18.6%)
ODD 5 (18.5%)
Table 3: MRI/working memory results (𝑁 = 27).
Average Standard deviation
Right hippoc. vola (mm3) 4191.05 416.30
Left hippoc. volb (mm3) 4174.79 506.74
Total hippoc. volc (mm3) 8365.85 901.58
BDNF (pg/𝜇g protein) 19.58 6.33
Digit Span TSd 6.66 1.83
Digit Span IOe 4.48 1.90
aRight hippocampus volume; bleft hippocampus volume; ctotal hippocam-
pus volume; all were determined with automatic segmentation method.
dDigit Span Total Score; eDigit Span Inverse Order.
number of psychoactive medications for children in this
group was 1.74.
Table 3 shows right hippocampus volume (RHV) and
left hippocampus volume (LHV), respectively, 4191.05 (mm3)
(SD = 416.30) and 4174.79mm3 (SD = 506.74), as determined
by automatic segmentation method. Total intracranial vol-
umemeanswere 1512863.14mm3 (SD= 151579.76). Peripheral
BDNF levels varied around 19.58 ± 6.33 (pg/𝜇g protein). The
average Digit Span Total Score was 6.66. The average Digit
Span Inverse Order was 4.48.
3.1. Primary Analysis. Table 4 shows correlation coefficients
of right hippocampus volume, left hippocampus volume,
and total hippocampus volume with BDNF. Those were,
consecutively, 0.15, 0.03, and 0.10, with significance levels
of 0.46, 0.89, and 0.62, respectively. After correction for
intracranial total volume, those values were, consecutively,
.090,−.125, and .007, with significance levels of .663, .544, and
.972 (Table 5).
Correlation coefficients between RHV, LHV, and THV
and the Digit Span Inverse Order were 0.02, 0.10, and 0.05,
respectively, and are also presented in Table 4. No correlation
was significant. We did not observe any correlations between
BDNF levels and disorder duration, as well as in working
memory as measured by the Digit Span Inverse Order test
(Table 6). Adjustment for intracranial total volume has not
shown a statistically significant correlation.
4. Discussion
In our evaluation of hippocampus volume and peripheral
levels in children and adolescents with bipolar disorder, no
statistically significant correlations were detected. The same
occurred with respect to working memory and disease dura-
tion. We emphasize that post hoc analyses were conducted,
evaluating peripheral BDNF levels and hippocampus volume
in patients with higher and lower disease duration. But still
no correlations were found.
Although studies in adults have been able to show the
relationship between peripheral BDNF levels and hippocam-
pus volume, we hypothesized that the lack of correlation
found in this study may represent the short time of evolution
of BD in children and adolescents. Usually in adult BD
studies, reduced BDNF levels are found in chronic or late-
stage individuals with BD, in comparison with patients in
early stages of the illness [11].The same occurs in neuroimag-
ing studies in bipolar disorder, meaning that the effects of
systemic toxicity, cognitive and functional impairment, and
biological changes seen in BD tend to be cumulative and
much more prominent after multiple episodes [23]. Thus,
these changes may not yet be found in patients with few years
of the disease, as occurs in children and adolescents with BD.
Even diseases that are proven to exert a strong influence
on hippocampusmorphology and structure, such as epilepsy,
may still not reveal changes in neuroimaging exams when in
children. For instance, studies of newly diagnosed epilepsy
typically fail to find many patients with clear structural
subcortical changes at the onset. Zhang et al. compared hip-
pocampus volumes in children with temporal lobe epilepsy
(TLE) and healthy controls using magnetic resonance imag-
ing. They have not found hippocampus volume reduction in
diagnosed definite/probable TLE children [24]. While there
is evidence from adult studies and studies in chronic epilepsy
patients that hippocampus atrophy may be a progressive
lesion, there is little information regarding hippocampus
abnormalities early in the course of epilepsy in patients,
particularly in children [25–27].
Our study was limited, in part, by the fact that we used a
convenience sample, due to the short time we had available.
Therefore, our sample only offered statistical power higher
than 80% to detect correlation coefficients higher than 0.5
using two-sided hypothesis tests with a significance level
of 0.05. In this way, the possibility of type 2 error cannot
be ruled out. Another limitation was the lack of a control
group for comparison of BDNF levels, which is a sugges-
tion to future researches. The inclusion of a control group
would allow the observation of developmental differences
not associated with BD. However, this is the first study
addressing brain volumetrics and peripheral biomarkers in
PBD, and our exploratory analyses suggest neurobiological
underpinnings of BD in children and adolescents may differ
from this same disorder in another developmental stage
(adult life). Besides that, most of our subjects were taking
psychotropic medications at the time of the assessment and
were euthymic.This is not uncommon given the ethical issues
inherent in discontinuing medication in children with severe
psychiatric illnesses. Previous investigations demonstrated
that antimanic and antidepressant agents may influence the
effects of BDNF on hippocampus, and that could induce
morphological changes in subcortical area in BD, which
could also lead to recovery of cognitive function. Due to
the cross-sectional design of our study, we cannot state that
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Table 4: Correlations between levels of BDNF, hippocampal volume, and neuropsychological measures.
RHVa LHVb THVc
𝜌 (rho) 𝑃 𝜌 (rho) 𝑃 𝜌 (rho) 𝑃
Disease duration .107 .595 .251 .207 .217 .276
BDNF .148 .461 .027 .892 .100 .621
IQ −.009 .963 .065 .749 .045 .825
Digit Span TSf −.098 .587 .102 .743 .014 .985
Digit Span IOg −.021 .918 .097 .632 .045 .825
aRight hippocampus volume; bleft hippocampus volume; ctotal hippocampus volume; dcorrelation coefficient; esignificance; fDigit Span Total Score; gDigit
Span Inverse Order.
Table 5: Correlations between levels of BDNF and hippocampal
volume controlling for intracranial volume.
RHVa LHVb THVc
𝜌 (rho) 𝑃 𝜌 (rho) 𝑃 𝜌 (rho) 𝑃
BDNF .090 .663 −.125 .544 .007 .972
aRight hippocampus volume; bleft hippocampus volume; ctotal hippocam-
pus volume.
Table 6: Correlation amongBDNFversus disease time, IQ, and digit
span.
BDNF
𝜌 (rho) 𝑃 value
Disease time .069 .731
IQ .069 .732
Digit span −.187 .351
medication use may have influenced the results. Also, we ran
additional analyses comparing results for patients who were
on and off medication, and no significant differences have
arisen [28–31].
Another limitation of our study was the use of auto-
matic segmentation method to measure and compare hip-
pocampal volumes. Manual and automatic segmentation
methods have been compared in some studies [32–34]. The
findings mostly validate the use of automatic methods for
segmentation of brain structures, confirming FreeSurfer’s
potential to determine hippocampal volumes in large-scale
studies, even though therewas a systematic volume difference
between FreeSurfer and manual results. Dewey et al. com-
pared FreeSurfer and individual brain atlases using statisti-
cal parametric mapping (IBASPM) to autoassisted manual
tracings [35]. They evaluated FreeSurfer to be effective for
subcortical volumetry but recommend visual inspection of
segmentation output along with manual correction to ensure
validity of the data. Wenger et al. compared automatic versus
manual segmentation in including 44 younger participants
(20–30 years) and 47 older participants (60–70 years) and
results reveal high stability coefficients over time for both
manual and FreeSurfer segmentations [36]. With FreeSurfer,
correlations over time were significantly lower in the older
than in the younger age group, which was not the case with
manual segmentation. Absolute agreements between the two
measures, however, were considerably lower, as FreeSurfer
estimated volumes to be higher. This volume difference was
larger in the young than in the old. FreeSurfer detected a
significant age difference in hippocampal volume, whereas
manual tracing did not. However, manual tracing resulted in
a significant difference between left and right Hc, whereas
FreeSurfer segmented both sides in a more similar manner.
They concluded that, in the younger age group, FreeSurfer
can be regarded as a reliable and valid method for assessing
differences in hippocampal volume, with at least as high
reliability as manual tracing.
The study of possible correlations between serum levels
of BDNF, working memory, and hippocampal volumetric
changes in patients with BD through neuroimaging can
make important contributions to the understanding of the
neurobiology of these disorders, such as how and when
the course of the disorder would play its effects on brain
development. Our findings suggest that, in early ages, brain
volumetric alterations may not be associated with the BDNF
peripheral levels and cognitive dysfunction.This information
raises the possibility that, in children and adolescents, BDNF
level changes must not be a priority when attempting to
prevent some of the future atrophic modifications.
Despite the lack of significant statistical correlation
observed in this study, this is the first study in pediatric
bipolar disorder correlating hippocampus volume andBDNF,
and no association between these factors was observed.
Replication for result confirmation is crucial, as well as
interpretation of these findings in the light of a developmental
context. Studies with larger samples and longitudinal studies
evaluating normal and disrupted brain development, which
include a control group and patients in different mood
episodes, may be able to clarify the role of BDNF in brain
changes caused by bipolar disorder.
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[27] C. A. Guimarães, L. Bonilha, R. C. Franzon, L. M. Li, F.
Cendes, and M. M. Guerreiro, “Distribution of regional gray
matter abnormalities in a pediatric population with temporal
lobe epilepsy and correlation with neuropsychological perfor-
mance,” Epilepsy and Behavior, vol. 11, no. 4, pp. 558–566, 2007.
[28] B. N. Frey, A. C. Andreazza, K. M. M. Ceresér et al., “Effects
of mood stabilizers on hippocampus BDNF levels in an animal
model of mania,” Life Sciences, vol. 79, no. 3, pp. 281–286, 2006.
[29] M. D. Hammonds and S. S. Shim, “Effects of 4-week treatment
with lithium and olanzapine on levels of brain-derived neu-
rotrophic factor, B-Cell CLL/Lymphoma 2 and phosphorylated
cyclic adenosine monophosphate response element-binding
protein in the sub-regions of the hippocampus,” Basic and
Clinical Pharmacology and Toxicology, vol. 105, no. 2, pp. 113–
119, 2009.
[30] L. G. Chepenik, C. Fredericks, X. Papademetris et al., “Effects
of the brain-derived neurotrophic growth factor Val66Met
variation on hippocampus morphology in bipolar disorder,”
Neuropsychopharmacology, vol. 34, no. 4, pp. 944–951, 2009.
[31] K. Yucel, M. C. McKinnon, V. H. Taylor et al., “Bilateral hip-
pocampal volume increases after long-term lithium treatment
in patients with bipolar disorder: a Longitudinal MRI study,”
Psychopharmacology, vol. 195, no. 3, pp. 357–367, 2007.
Neural Plasticity 7
[32] N. Cherbuin, K. J. Anstey, C. Réglade-Meslin, and P. S. Sachdev,
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